Review
Oral iron chelators
- PMID: 2572743
Item in Clipboard
Review
Oral iron chelators
Lancet.
.
No abstract available
Comment in
-
Clinical trials with oral iron chelator L1.Lancet. 1989 Dec 23-30;2(8678-8679):1516-7. doi: 10.1016/s0140-6736(89)92952-8. Lancet. 1989. PMID: 2574781 Clinical Trial. No abstract available.
Similar articles
-
Deferiprone for thalassaemia.Lancet. 2000 Oct 21;356(9239):1444-5. doi: 10.1016/S0140-6736(05)74089-7. Lancet. 2000. PMID: 11052617 No abstract available.
-
Clinical trials with oral iron chelator L1.Lancet. 1989 Dec 23-30;2(8678-8679):1516-7. doi: 10.1016/s0140-6736(89)92952-8. Lancet. 1989. PMID: 2574781 Clinical Trial. No abstract available.
-
Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption.Clin Exp Optom. 2009 Jul;92(4):392-4. doi: 10.1111/j.1444-0938.2009.00385.x. Epub 2009 Jun 10. Clin Exp Optom. 2009. PMID: 19515094 No abstract available.
-
Advances in oral iron chelation in man.Int J Hematol. 1992 Feb;55(1):27-38. Int J Hematol. 1992. PMID: 1581581 Review. No abstract available.
-
Oral iron chelation.Semin Hematol. 1996 Jan;33(1):1-8. Semin Hematol. 1996. PMID: 8714581 Review. No abstract available.
Cited by
-
The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases.Pharmaceuticals (Basel). 2023 Jul 18;16(7):1016. doi: 10.3390/ph16071016. Pharmaceuticals (Basel). 2023. PMID: 37513928 Free PMC article. Review.
-
Drug antioxidant effects. A basis for drug selection?Drugs. 1991 Oct;42(4):569-605. doi: 10.2165/00003495-199142040-00003. Drugs. 1991. PMID: 1723362 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
